Literature DB >> 3363861

Characterization of the double-stranded RNA implicated in the inhibition of protein synthesis in cells infected with a mutant adenovirus defective for VA RNA.

A Maran1, M B Mathews.   

Abstract

In the absence of VA RNAI, protein synthesis in adenovirus-infected HeLa cells fails at late times of infection because of defective initiation. The defect is due to the activation of a protein kinase that phosphorylates the alpha-subunit of initiation factor eIF-2. The kinase responsible for the translational defect is DAI, the double-stranded RNA (dsRNA)-activated inhibitor of protein synthesis, which is present in uninfected HeLa cells at a basal level and in a largely inactive, latent state. In vitro it can be activated by incubation with ATP and low concentration of dsRNA. Previous studies suggested that RNA generated during the course of infection can activate DAI. We show here that the activator RNA has the properties of dsRNA: it chromatographs with dsRNA, can be denatured and reannealed, and is destroyed by a dsRNA-specific nuclease. At least some of the dsRNA is viral. It hybridizes to DNA sequences in the center of the viral genome, principally between map units 47 and 51 and 73 and 76, consistent with an origin in the symmetrical transcription of both viral DNA strands.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3363861     DOI: 10.1016/0042-6822(88)90625-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  54 in total

1.  Translational stimulation by reovirus polypeptide sigma 3: substitution for VAI RNA and inhibition of phosphorylation of the alpha subunit of eukaryotic initiation factor 2.

Authors:  R M Lloyd; A J Shatkin
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis.

Authors:  Shihua Lu; Bryan R Cullen
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNAI from a T7 vector.

Authors:  K H Mellits; T Pe'ery; L Manche; H D Robertson; M B Mathews
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

4.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs.

Authors:  R J Kaufman; M V Davies; V K Pathak; J W Hershey
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

Review 5.  Antiviral silencing in animals.

Authors:  Hong-Wei Li; Shou-Wei Ding
Journal:  FEBS Lett       Date:  2005-08-31       Impact factor: 4.124

6.  Suppression of RNA interference by adenovirus virus-associated RNA.

Authors:  M Gunnar Andersson; P C Joost Haasnoot; Ning Xu; Saideh Berenjian; Ben Berkhout; Göran Akusjärvi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells.

Authors:  T G Lee; J Tomita; A G Hovanessian; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

8.  Partial characterization of a cellular factor that regulates the double-stranded RNA-dependent eIF-2 alpha kinase in 3T3-F442A fibroblasts.

Authors:  R Judware; R Petryshyn
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

9.  Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system.

Authors:  M G Katze; M Wambach; M L Wong; M Garfinkel; E Meurs; K Chong; B R Williams; A G Hovanessian; G N Barber
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

10.  Activation of RNA polymerase III transcription of human Alu repetitive elements by adenovirus type 5: requirement for the E1b 58-kilodalton protein and the products of E4 open reading frames 3 and 6.

Authors:  B Panning; J R Smiley
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.